MarketCap
Facebook
X
TelegramGeschäftsbericht 2024
hinzugefügt 04.03.2025
Nevro Corp. Kurzfristige Verbindlichkeiten 2011-2026 | NVRO
Kurzfristige Verbindlichkeiten Jährlich Nevro Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 103 M | 83.4 M | 79.2 M | 82.2 M | 239 M | 70.6 M | 62.4 M | 58 M | 42.2 M | 36.4 M | 10.8 M | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 239 M | 10.8 M | 78.8 M |
Kurzfristige Verbindlichkeiten anderer Aktien in der Medizinische Geräte
| Name | Kurzfristige Verbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Aethlon Medical
AEMD
|
1.9 M | $ 2.2 | 4.27 % | $ 3.43 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
712 M | $ 10.72 | 2.88 % | $ 1.45 B | USA |
 |
Allied Healthcare Products
AHPI
|
5.98 M | - | 3.58 % | $ 2.21 M | USA |
 |
Butterfly Network
BFLY
|
48.2 M | $ 4.17 | 6.52 % | $ 883 M | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
44.1 M | - | - | $ 1.77 B | USA |
 |
Acutus Medical
AFIB
|
18.9 M | - | -26.83 % | $ 2.62 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
219 M | $ 8.37 | -0.12 % | $ 601 M |  Israel |
 |
CONMED Corporation
CNMD
|
315 M | $ 36.49 | -2.47 % | $ 1.13 B | USA |
 |
Alphatec Holdings
ATEC
|
219 M | $ 12.76 | 1.23 % | $ 1.91 B | USA |
 |
Cytosorbents Corporation
CTSO
|
9.82 M | $ 0.69 | 6.49 % | $ 37.6 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
5.05 M | - | -5.86 % | $ 30.6 M | USA |
 |
Aziyo Biologics
AZYO
|
25.1 M | - | 1.37 % | $ 20.5 M | USA |
 |
Avinger
AVGR
|
19.3 M | - | -20.74 % | $ 369 K | USA |
 |
EDAP TMS S.A.
EDAP
|
37.8 M | $ 4.12 | 3.91 % | $ 154 M |  France |
 |
BIOLASE
BIOL
|
19.7 M | - | -13.19 % | $ 166 K | USA |
 |
Boston Scientific Corporation
BSX
|
5.44 B | $ 71.64 | 2.65 % | $ 106 B | USA |
 |
Establishment Labs Holdings
ESTA
|
82.1 M | $ 65.1 | 2.55 % | $ 1.93 B |  Costa-rica |
 |
Conformis
CFMS
|
14.1 M | - | - | $ 16.4 M | USA |
 |
Apollo Endosurgery
APEN
|
39.5 M | - | - | $ 475 M | USA |
 |
Cutera
CUTR
|
87.7 M | - | -10.19 % | $ 1.99 M | USA |
 |
CryoLife, Inc.
CRY
|
60.5 M | - | -4.14 % | $ 702 M | USA |
 |
Dynatronics Corporation
DYNT
|
8.24 M | - | 14.99 % | $ 929 K | USA |
 |
ClearPoint Neuro
CLPT
|
10.4 M | $ 11.29 | 2.32 % | $ 305 M | USA |
 |
InMode Ltd.
INMD
|
70.7 M | $ 13.58 | 1.11 % | $ 878 M | Israel |
 |
IRIDEX Corporation
IRIX
|
13 M | $ 1.31 | -1.5 % | $ 21.1 M | USA |
 |
Axonics Modulation Technologies
AXNX
|
65.2 M | - | - | $ 3.31 B | USA |
 |
Soliton, Inc.
SOLY
|
2.82 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
3.19 K | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
18 M | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
17.3 M | - | - | $ 462 M | USA |
 |
FONAR Corporation
FONR
|
16.7 M | $ 18.44 | 0.11 % | $ 121 M | USA |
 |
Helius Medical Technologies
HSDT
|
1.88 M | $ 2.2 | 0.46 % | $ 1.34 M | USA |
 |
LivaNova PLC
LIVN
|
808 M | $ 62.23 | 1.29 % | $ 3.39 B |  Britain |
 |
GBS
GBS
|
5.35 M | - | -0.57 % | $ 7.12 M | USA |
 |
MiMedx Group
MDXG
|
64.3 M | $ 4.47 | 1.25 % | $ 661 M | USA |
 |
Intersect ENT, Inc.
XENT
|
44.2 M | - | - | $ 955 M | USA |
 |
Abbott Laboratories
ABT
|
16.5 B | $ 111.62 | 1.52 % | $ 194 B | USA |
 |
Delcath Systems
DCTH
|
11 M | $ 9.76 | -0.48 % | $ 350 M | USA |
 |
Bio-Rad Laboratories
BIO
|
468 M | $ 268.07 | 2.61 % | $ 7.56 B | USA |
 |
Nano-X Imaging Ltd.
NNOX
|
14 M | $ 2.59 | -0.19 % | $ 152 M | Israel |
 |
Integra LifeSciences Holdings Corporation
IART
|
922 M | $ 9.19 | 2.0 % | $ 708 M | USA |
 |
AxoGen
AXGN
|
23.6 M | $ 32.83 | -0.05 % | $ 1.51 B | USA |
 |
Align Technology
ALGN
|
2.04 B | $ 176.11 | 3.93 % | $ 13.2 B | USA |
 |
Bruker Corporation
BRKR
|
1.28 B | $ 33.64 | 2.67 % | $ 5.01 K | USA |
 |
BioSig Technologies
BSGM
|
2.26 M | - | 37.08 % | $ 85.7 M | USA |
 |
Apyx Medical Corporation
APYX
|
11.7 M | $ 3.82 | 4.08 % | $ 157 M | USA |
 |
OrthoPediatrics Corp.
KIDS
|
46.2 M | $ 17.1 | -0.06 % | $ 401 M | USA |